2011 Speakers



Labeeb  Abboud

Labeeb Abboud
Senior Vice President and General Counsel, International AIDS Vaccine Initiative

Margaret   Anderson

Margaret Anderson
Executive Director, FasterCures/The Center for Accelerating Medical Solutions


Ramsey   Baghdadi

Ramsey Baghdadi
Managing Editor, The RPM Report

Rashmi  Barbhaiya

Rashmi Barbhaiya
Chief Executive Officer and Managing Director, Advinus Therapeutics

Anna  Barker

Anna Barker
Director, Transformative Healthcare Networks, Co-Director, Complex Adaptive Systems Initiative and Professor, School of Life Sciences, Arizona State University

Eileen   Bartholomew

Eileen Bartholomew
Senior Director, Life Sciences, X PRIZE Foundation

Robert J. Beall

Robert J. Beall
President and CEO, Cystic Fibrosis Foundation

Michael   Beckloff

Michael Beckloff
President, Beckloff Associates, Inc.

Gordon  R.  Bernard

Gordon R. Bernard
Professor of Medicine, Associate Vice Chancellor for Research, and Senior Associate Dean for Clinical Science, Vanderbilt University

Leon   Black

Leon Black
Co-Founder, Melanoma Research Alliance, Board Member, FasterCures, CEO, Apollo Management LP

Enriqueta (Queta)  Bond

Enriqueta (Queta) Bond
Partner, QE Philanthropic Advisors

Jeffrey   Brewer

Jeffrey Brewer
President and CEO, Juvenile Diabetes Research Foundation

L. Russell "Rusty"  Bromley

L. Russell "Rusty" Bromley
Principal, TRAC Consulting

Timothy  N.  Bullock

Timothy N. Bullock
Associate Professor, Department of Pathology Human Immune Therapy Center, University of Virginia

Brook  Byers

Brook Byers
Partner, Kleiner Perkins Caufield & Byers

Maureen   Byrnes

Maureen Byrnes
Former Executive Director of the National Commission on AIDS


Michael   Cembalest

Michael Cembalest
Global Head of Investment Strategy, J.P. Morgan

Timothy   Coetzee

Timothy Coetzee
Chief Research Officer, National Multiple Sclerosis Society

Ron  Cohen

Ron Cohen
President and Chief Executive Officer, Acorda Therapeutics, Inc

N. Anthony   Coles

N. Anthony Coles
President, Chief Executive Officer and Member of the Board, Onyx Pharmaceuticals

Anthony  Coyle

Anthony Coyle
Vice President and CSO, Centers for Therapeutic Innovation, Pfizer, Inc.

Jason   Cummins

Jason Cummins
Chief U.S. Economist and Head of Research, Brevan Howard Inc


Louis  DeGennaro

Louis DeGennaro
Chief Mission Officer, Leukemia & Lymphoma Society

Susan  Desmond-Hellmann

Susan Desmond-Hellmann
Chancellor, University of California, San Francisco

Ross  C. DeVol

Ross C. DeVol
Chief Research Officer, Milken Institute

Susan  Wolf  Ditkoff

Susan Wolf Ditkoff
Partner, The Bridgespan Group

Mary  Dwight

Mary Dwight
Vice President of Government Affairs, Cystic Fibrosis Foundation


Aled  M.  Edwards

Aled M. Edwards
Chief Executive, Structural Genomics Consortium


Howard  Fillit

Howard Fillit
Executive Director, Alzheimer's Drug Discovery Foundation

Garret  FitzGerald

Garret FitzGerald
Robert L. McNeil, Jr., Professor in Translational Medicine and Therapeutics, University of Pennsylvania

Valentina  Fossati

Valentina Fossati
New York Stem Cell Foundation - Helmsley Investigator, The New York Stem Cell Foundation Laboratory

Stephen  Friend

Stephen Friend
President, Sage Bionetworks


Brent  Gendleman

Brent Gendleman
President and Chief Executive Officer, 5AM Solutions

Kathy  Giusti

Kathy Giusti
Founder and Chief Executive Officer, Multiple Myeloma Research Foundation

George  Golumbeski

George Golumbeski
Senior Vice President of Business Development, Celgene Corporation

James  C.  Greenwood

James C. Greenwood
President and CEO, Biotechnology Industry Organization (BIO)

Carol  Greve-Philips

Carol Greve-Philips
Former Vice President, Corporate Development, Genzyme Corporation


Margaret A. Hamburg

Margaret A. Hamburg
Commissioner, U.S. Food and Drug Administration

Paula  Hammond

Paula Hammond
Bayer Chair Professor of Chemical Engineering, Massachusetts Institute of Technology

Brian   Harvey

Brian Harvey
Vice President, U.S. Regulatory Policy, Sanofi

Katie   Hood

Katie Hood
Senior Fellow and Visiting Lecturer, Hart Leadership Program at Duke University's Sanford School of Public Policy

Katie  Hood

Katie Hood
Former Chief Executive Officer, Michael J. Fox Foundation for Parkinson's Research

Kathy  Hudson

Kathy Hudson
Deputy Director for Science, Outreach, and Policy, National Institutes of Health

Hoyoung   Huh

Hoyoung Huh
Chairman of the Board, Geron Corporation


Thomas  R.  Insel

Thomas R. Insel
Director, National Institute of Mental Health (NIMH), National Institutes of Health


Kris   Joshi

Kris Joshi
Global Vice President - Healthcare, Oracle


Thomas  Kalil

Thomas Kalil
Deputy Director for Policy, White House Office of Science and Technology Policy

Regis  B. Kelly

Regis B. Kelly
Director, The California Institute for Quantitative Biosciences (QB3), University of California

Eric  Kessler

Eric Kessler
Principal and Managing Director, Arabella Philanthropic Investment Advisors

Annette  Kleiser

Annette Kleiser
Senior Program Officer, Industry Alliances, University of Southern California Stevens Institute

Annette   Kleiser

Annette Kleiser
Senior Program Officer, Industry Initiatives, USC Stevens Institute for Innovation, University of Southern California

Fernando  Kreutz

Fernando Kreutz
Founder and President, FK-Biotec

Mark  Krueger

Mark Krueger
Mark Krueger & Associates


Warren  B. Lammert

Warren B. Lammert
Chairman and Co-Founder, The Epilepsy Therapy Project

Peter  Lansbury, Jr.

Peter Lansbury, Jr.
Chief Scientific Officer, LINK Medicine and Professor of Neurology, Harvard Medical School

Debra R.  Lappin

Debra R. Lappin
President, Council for American Medical Innovation; Senior Vice President, B&D Consulting

Daniel  Laster

Daniel Laster
General Counsel, Legal Affairs, PATH

Barbara  Lavery

Barbara Lavery

Jonathan  Leff

Jonathan Leff
Managing Director, Healthcare, Warburg Pincus

Susan   Love

Susan Love
President and Medical Director, Dr. Susan Love Research Foundation

David  Lubitz

David Lubitz
Schaner & Lubitz


Michael   Manganiello

Michael Manganiello
Partner, HCM Strategists

David M. Margulies

David M. Margulies
Senior Associate in Medicine and Director of The Gene Partnership (TGP), Children's Hospital Boston

James  McCullough

James McCullough
Chief Executive Officer, Exosome Diagnostics, Inc.

Gerald  McDougall

Gerald McDougall
Principal, Personalized Medicine and Health Sciences Practices,PricewaterhouseCoopers

John  McKew

John McKew
Chief, Therapeutic Development Branch, National Center for Translational Therapeutics, National Institutes of Health

Teri  Melese

Teri Melese
Associate Professor of Medicine and Director of Research Technologies and Alliances, School of Medicine, Dean's Office, University of California, San Francisco

Teri  Melese

Teri Melese
Associate Professor Medicine and Director Research Technologies and Alliances, UCSF School of Medicine

Gwen  A. Melincoff

Gwen A. Melincoff
Senior Vice President, Business Development, Strategic Investment Group, Shire Pharmaceuticals

John  Mendlein

John Mendlein
Executive Chairman, Fate Therapeutics and Chairman, aTyr Pharma

Michael   Milken

Michael Milken
Chairman, Milken Institute and Chairman, FasterCures

Lesa  Mitchell

Lesa Mitchell
Vice President, Ewing Marion Kauffman Foundation

Chris   Morrison

Chris Morrison
Editor-in-Chief, Biopharmaceuticals and Consumer Products at Elsevier Business Intelligence


Larry  A. Nagahara

Larry A. Nagahara
Acting Director, Office of Physical Sciences-Oncology, National Cancer Institute

Garry  Neil

Garry Neil
Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson

Eric  Nelson

Eric Nelson
Business development consultant

Sean  Nolan

Sean Nolan
Chief Architect and General Manager, Health Solutions Group, Microsoft Corp.


Kyle  Peterson

Kyle Peterson
FSG Social Impact Advisors

Dennis G. Podlesak

Dennis G. Podlesak
Partner, Domain Associates

George  Poste

George Poste
Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University


Raul   Rabadan

Raul Rabadan
Assistant Professor, Department of Biomedical Informatics, Center for Computational Biology and Bioinformatics, Columbia University College of Physicians and Surgeons

Michael  Rawlins

Michael Rawlins
Chairman, National Institute of Health and Clinical Excellence

Susan   Rohrer

Susan Rohrer
Senior Director, External Scientific Affairs, Worldwide Licensing, Merck Research Laboratories


Ken  Schaner

Ken Schaner
Managing Partner, Schaner & Lubitz

Mark  Scheideler

Mark Scheideler
formerly NIH/NINDS

Marie  Schiller

Marie Schiller
Partner, Health Advances LLC

Melanie  Schnoll Begun

Melanie Schnoll Begun
Mananaging Director and Head of Morgan Stanley Private Wealth Management's Philanthropic Services

Wendy  Selig

Wendy Selig
President and CEO, Melanoma Research Alliance

Sebastian   Seung

Sebastian Seung
Professor of Computational Neuroscience, MIT; author of Connectome: How the Brain's Wiring Makes Us Who We Are

Padmanee   Sharma

Padmanee Sharma
Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Todd  Sherer

Todd Sherer
Chief Executive Officer, Michael J. Fox Foundation for Parkinson's Research

Jeffrey  Shuren

Jeffrey Shuren
Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration

Ellen V. Sigal

Ellen V. Sigal
Chair and Founder, Friends of Cancer Research

Greg  Simon

Greg Simon
Senior Vice President, Patient Engagement, Pfizer Inc.

Josh  Sommer

Josh Sommer
Executive Director, Chordoma Foundation

Stephen  P. Spielberg

Stephen P. Spielberg
Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration

David   Steinberg

David Steinberg
Partner, PureTech Ventures

Melissa   Stevens

Melissa Stevens
Director of Strategic Initiatives, FasterCures

Brent  Stockwell

Brent Stockwell
Associate Professor, Biological Science, Columbia University


Jeffrey  M. Trent

Jeffrey M. Trent
President and Research Director, Van Andel Research Institute; President and Research Director, The Translational Genomics Research Institute (TGen)

Reed  Tuckson

Reed Tuckson
Executive Vice President and Chief of Medical Affairs, UnitedHealth Group


Steve   Usdin

Steve Usdin
Senior Editor (Washington), BioCentury


Chris  Varma

Chris Varma
Entrepreneur-in-Residence, Third Rock Ventures

George  Vradenburg

George Vradenburg
Chairman, USAgainstAlzheimer's


Scott  J. Weir

Scott J. Weir
Director, Institute for Advancing Medical Innovation, University of Kansas Cancer Center

Michael  Werner

Michael Werner
Partner, Holland & Knight

Timothy  M. Wright

Timothy M. Wright
Global Head of Translational Sciences, Novartis Institutes for BioMedical Research (NIBR)